Compugen Ltd (CGEN) stock
CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)
Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –
Compugen market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Compugen's market cap was $197.97M on Nov 11, 2026, against $145.92M a year earlier. Over the last 5 years it ranged from $51.11M to $360.85M, with a median of $159.38M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $197.97M | +38.3% |
| 2025 | Dec 31, 2025 | $143.11M | +4.5% |
| 2024 | Dec 31, 2024 | $136.98M | -21.6% |
| 2023 | Dec 29, 2023 | $174.70M | +181.8% |
| 2022 | Dec 30, 2022 | $62.00M | -82.8% |
| 2021 | Dec 31, 2021 | $360.85M | -64.0% |
| 2020 | Dec 31, 2020 | $1.00B | +171.2% |
| 2019 | Dec 31, 2019 | $369.26M | +197.5% |
| 2018 | Dec 31, 2018 | $124.12M | -2.9% |
| 2017 | Dec 29, 2017 | $127.83M | -50.8% |
| 2016 | Dec 30, 2016 | $259.63M | -19.5% |
| 2015 | Dec 31, 2015 | $322.44M | -20.1% |
| 2014 | Dec 31, 2014 | $403.74M | +17.6% |
| 2013 | Dec 31, 2013 | $343.33M | +93.9% |
| 2012 | Dec 31, 2012 | $177.07M | +5.5% |
| 2011 | Dec 30, 2011 | $167.88M | +3.8% |
| 2010 | Dec 31, 2010 | $161.71M | – |
See a number that looks wrong?